Could a new stomach surgery help control diabetes in gastric cancer patients?
NCT ID NCT07437573
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a longer intestinal bypass during stomach cancer surgery improves diabetes control better than the standard method. It included 94 adults with early-stage gastric cancer and type 2 diabetes. Researchers measured blood sugar and hormone levels one year after surgery to compare outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
94 people
The number who actually took part.
- Started
-
Jul 2020
- Finished
-
May 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 79 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Clinical Stage I Gastric Cancer * a patient aged 20 to 80 * Dx of Type 2 Diabetes * Preoperative BMI ≥ 23 kg/m2 Exclusion Criteria: * If you have a history of cancer other than gastric cancer in the last five years * If you received chemotherapy treatment before gastric cancer surgery * Preoperative advanced gastric cancer is diagnosed, or gastric total resection is performed in the upper part * If you have a history of malabsorption
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gastric cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Korea University Guro Hospital
Seoul, Gurogu, 08308, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a personalized menu keep cancer patients stronger through chemotherapy?
- Can mindfulness and yoga rewire diabetes habits?
- Can a vegan diet delivered online help people with type 2 diabetes?
- Nerve-Block procedure tested against severe pancreatic and stomach cancer pain
- Tiny horses, big lessons: can ponies help kids tame diabetes?
- Robotic surgery vs standard approaches: does the platform change cancer outcomes?